Agile Therapeutics, Inc.

0.85 USD
-0.03 (-3.42%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Agile Therapeutics, Inc. stock is down -46.2% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 9 February’s closed higher than January.

About Agile Therapeutics, Inc.

Agile Therapeutics, Inc. researches, develops, and commercializes prescription contraceptive products. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of line extensions and other products.